O. Hansen

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial

K. Grønbæk, K. Thorling, J. Pedersen‐Bjergaard, 1997, Leukemia.